Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,996
datasets available to search
ShareScore release 0.9.0
Dataset results
2,996 results for “copd”
Study to Assess the Efficacy and Safety of AZD1981 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
ClinicalTrials.gov study NCT00690482. IPD Sharing: Not stated. Countries: 5. Publications: 1.
A Study to Assess the Efficacy, Safety and Tolerability of Once-daily (q.d.) QVA149 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
ClinicalTrials.gov study NCT01202188. IPD Sharing: Not stated. Countries: 19. Publications: 1.
N-Acetylcysteine for Patients With COPD and Chronic Bronchitis
ClinicalTrials.gov study NCT01739790. IPD Sharing: NO. Countries: 1. Publications: 1.
Phase 1 Study Into Pharmacokinetics and Food Effect of Vapendavir in Healthy Participants and Participants With COPD
ClinicalTrials.gov study NCT05962645. IPD Sharing: NO. Countries: 1. Publications: 12.
Evaluate the Effect of Aclidinium Bromide on Long-term Cardiovascular Safety and Exacerbations in Moderate to Very Severe COPD Patients.
ClinicalTrials.gov study NCT01966107. IPD Sharing: Not stated. Countries: 2. Publications: 4.
Swiss studY for the Treatment of COPD Patients With the Free combiNation of indacatERol and GlYcopyrroniumbromide.
ClinicalTrials.gov study NCT01699685. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Effect of QVA149 Versus NVA237 and Tiotropium on Chronic Obstructive Pulmonary Disorder (COPD) Exacerbations
ClinicalTrials.gov study NCT01120691. IPD Sharing: Not stated. Countries: 28. Publications: 1.
An Implementation Trial to Improve Access to Pulmonary Rehabilitation in People With COPD
ClinicalTrials.gov study NCT04217330. IPD Sharing: YES. Countries: 1. Publications: 2.
Deep Learning Diagnostic and Risk-stratification for IPF and COPD
ClinicalTrials.gov study NCT05318599. IPD Sharing: YES. Countries: 1. Publications: 1.
Single Dose Study to Assess Efficacy and Safety of 4 Doses of LAS100977 in Chronic Obstructive Pulmonary Disease (COPD) Population
ClinicalTrials.gov study NCT01425814. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Frespaciguat (MK-5475) in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD) (MK-5475-006)
ClinicalTrials.gov study NCT04370873. IPD Sharing: YES. Countries: 3. Publications: 1.
Chronic Obstructive Pulmonary Disease (COPD) Post-hospitalization Study
ClinicalTrials.gov study NCT01110200. IPD Sharing: YES. Countries: 3. Publications: 1.
Nitric Oxide Bioavailability in Chronic Obstructive Pulmonary Disease (COPD)
ClinicalTrials.gov study NCT01398943. IPD Sharing: YES. Countries: 1. Publications: 62.
Efficacy and Safety of Four Doses of Glycopyrronium Bromide (NVA237) in Patients With Stable Chronic Obstructive Pulmonary Disease (COPD), in Comparison to an Active Comparator Tiotropium
ClinicalTrials.gov study NCT00501852. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Diaphragmatic Function and Respiratory Drive in OSA and COPD
ClinicalTrials.gov study NCT07003399. IPD Sharing: NO. Countries: 1. Publications: 6.
Revefenacin Peak Inspiratory Flow Rate (PIFR) Study in COPD
ClinicalTrials.gov study NCT03095456. IPD Sharing: Not stated. Countries: 1. Publications: 3.
A 6-month Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
ClinicalTrials.gov study NCT01053988. IPD Sharing: YES. Countries: 10. Publications: 3.
A 24-week Study of Fluticasone Furoate/Vilanterol Inhalation Powder in Subjects of Asian Ancestry With COPD
ClinicalTrials.gov study NCT01376245. IPD Sharing: YES. Countries: 4. Publications: 1.
Glycopyrronium and Formoterol Fumarate (GFF) Metered Dose Inhaler (MDI) Dose Indicator Study in Adults With Moderate to Very Severe COPD
ClinicalTrials.gov study NCT02268396. IPD Sharing: Not stated. Countries: 1. Publications: 1.
PT001 MDI Versus Spiriva® in Patients With Moderate to Severe COPD
ClinicalTrials.gov study NCT01566773. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.